Week Ending March 14, 2022

Universal Screening for Hepatitis C in Pregnant Women
“Universal screening is more sensitive in detecting hepatitis C virus (HCV) than risk‑based screening in the general obstetric population, according to the results of a study presented at the 2022 Conference for Antiretrovirals and Opportunistic Infections (CROI).”

Hepatocellular carcinoma surveillance, incidence, and tumor doubling times in patients cured of hepatitis C
“Hepatocellular carcinoma (HCC) incidence and mortality vary by race/ethnicity and both are higher in Black patients than in Whites. For HCC surveillance, all cirrhotic patients are advised to undergo lifelong twice-annual abdominal imaging. We investigated factors associated with surveillance and HCC incidence in a diverse HCC risk group, cirrhotic patients recently cured of hepatitis C virus (HCV) infection.”

Disparities in the quality of care for chronic hepatitis C among Medicare beneficiaries
“Chronic hepatitis C virus (HCV) infection is an important public health concern. Limited information exists on disparities in the quality of HCV care. We examine disparities in genotype or quantitative HCV ribonucleic acid testing before and after starting HCV treatment, and screening for hepatocellular carcinoma (HCC) in HCV patients with cirrhosis.”